SCHEMBL349313

SCHEMBL349313

[CH2]c1cccc(C(C)(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 3/20 0.47
HDAC4 P56524 1/20 0.47
HDAC2 Q92769 1/20 0.47
KIF11 P52732 3/20 0.45
ACHE P22303 4/20 0.42
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
ALDH1A1 P00352 3/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPC1 O15118 1/20 0.38
PLA2G1B P04054 1/20 0.38
NFKB1 P19838 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
SENP8 Q96LD8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28141491 0.83 ESR1 (0.34) HDAC8HDAC4HDAC2KIF11ESR1
SCHEMBL127219 0.81 ESR1 (0.38) HDAC8HDAC4HDAC2KIF11ACHE
SCHEMBL129151 0.81 HDAC8 (0.56) HDAC8HDAC4HDAC2KIF11ACHE
Water SCHEMBL29289408 0.78 HDAC8 (0.54) HDAC8HDAC4HDAC2KIF11ACHE
SCHEMBL2223264 0.77 TSHR (0.30) TSHR
SCHEMBL28324137 0.76 TSHR (0.50) ALDH1A1L3MBTL1TSHRNOTUM
SCHEMBL97209 0.75 TSHR (0.54) ALDH1A1TDP1GAAMAPTTSHR
SCHEMBL2224945 0.75 TSHR (0.48) TSHR
SCHEMBL2223817 0.75
SCHEMBL125514 0.74 MAPT (0.42) HDAC8HDAC4HDAC2ACHERXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024104384-A1 INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS NUCMITO PHARMACEUTICALS CO. LTD. (CN) 2024-05-23 WO claimed
US-20230278958-A1 TRICYCLIC HETEROCYCLES MERCK PATENT GMBH (DE) 2023-09-07 US claimed
US-20230174538-A1 Tricyclic heterocycles MERCK PATENT GMBH (DE) 2023-06-08 US claimed
EP-4185564-A1 TRICYCLIC HETEROCYCLES Merck Patent GmbH (DE) 2023-05-31 EP claimed
CN-116134016-A Tricyclic heterocycles 默克专利股份公司 2023-05-16 CN claimed
WO-2023078813-A1 HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS MERCK PATENT GMBH (DE) 2023-05-11 WO claimed
EP-4146652-A1 TRICYCLIC HETEROCYCLES USEFUL AS TEAD BINDERS Merck Patent GmbH (DE) 2023-03-15 EP claimed
CN-115515959-A Tricyclic heterocycles as TEAD binders 默克专利股份公司 2022-12-23 CN claimed
CN-114160210-A Catalyst for selective tetramerization of ethylene and preparation method and application thereof 华东理工大学 2022-03-11 CN claimed
WO-2021224291-A1 TRICYCLIC HETEROCYCLES USEFUL AS TEAD BINDERS MERCK PATENT GMBH (DE) 2021-11-11 WO claimed
CN-113600241-A Catalyst system for selective trimerization of ethylene and preparation and application thereof 华东理工大学 2021-11-05 CN claimed
US-20210277014-A1 (S)-3-(2-(4-(BENZYL)-3-OXOPIPERAZIN-1-YL)ACETAMIDO)-4-OXO-5-(2,3,5,6-TETRAFLUOROPHENOXY)PENTANOIC ACID DERIVATIVES AND RELATED COMPOUNDS AS CASPASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES HISTOGEN, INC. 2021-09-09 US claimed
EP-3814327-A1 (S)-3-(2-(4-(BENZYL)-3-OXOPIPERAZIN-1-YL)ACETAMIDO)-4-OXO-5-(2,3,5,6-TETRAFLUOROPHENOXY)PENTANOIC ACID DERIVATIVES AND RELATED COMPOUNDS AS CASPASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES Histogen, Inc. (US) 2021-05-05 EP claimed
EP-2411564-B1 ELECTROCHEMICAL PROCESS FOR PRODUCING 3-TERT-BUTYLBENZALDEHYDE-DIMETHYLACETAL BASF SE (DE) 2017-05-10 EP claimed
US-8629304-B2 Electrochemical method for producing 3-tert-butylbenzaldehyde dimethyl acetal BASF SE (DE) 2014-01-14 US claimed
US-20120016162-A1 ELECTROCHEMICAL METHOD FOR PRODUCING 3-TERT-BUTYLBENZALDEHYDE DIMETHYL ACETAL BASF SE (DE) 2012-01-19 US claimed
WO-2009038412-A2 BETA-SECRETASE INHIBITING COMPOUNDS LG LIFE SCIENCES, LTD. (KR) 2009-03-26 WO claimed
US-12012475-B2 Method of olefin polymerization using alkane-soluble non-metallocene precatalyst DOW GLOBAL TECHNOLOGIES LLC (US) 2024-06-18 US disclosed
US-3988471-A Insect control employing certain benzoates CHEVRON RESEARCH COMPANY (US) 1976-10-26 US disclosed
US-3936462-A CNS DEPRESSANT, ANALGESIC STERLING DRUG INC. (US) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210277014-A1 (S)-3-(2-(4-(BENZYL)-3-OXOPIPERAZIN-1-YL)ACETAMIDO)-4-OXO-5-(2,3,5,6-TETRAFLUOROPHENOXY)PENTANOIC ACID DERIVATIVES AND RELATED COMPOUNDS AS CASPASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES CASP1, CASP3, CASP6 HDAC8 709/4885HDAC4 445/4885HDAC2 307/4885
US-20230278958-A1 TRICYCLIC HETEROCYCLES YAP1, TERF2IP, TEAD1 HDAC8 871/4885HDAC4 1943/4885HDAC2 2216/4885
US-20230174538-A1 Tricyclic heterocycles YAP1, TEAD1, TERF2IP HDAC8 773/4885HDAC4 1608/4885HDAC2 1990/4885
US-20120016162-A1 ELECTROCHEMICAL METHOD FOR PRODUCING 3-TERT-BUTYLBENZALDEHYDE DIMETHYL ACETAL TET3, TERT, ALKBH2 HDAC8 691/4885HDAC4 832/4885HDAC2 311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.